• Return to Headlines

Merrimack Pharma Has Returned 48.1% Since SmarTrend Recommendation (MACK)

By Nick Russo

SmarTrend identified a Downtrend for Merrimack Pharma (NASDAQ:MACK) on December 6th, 2017 at $10.55. In approximately 9 months, Merrimack Pharma has returned 48.06% as of today's recent price of $5.48.

In the past 52 weeks, Merrimack Pharma share prices have been bracketed by a low of $1.13 and a high of $15.40 and are now at $5.48, 385% above that low price. The 200-day and 50-day moving averages have moved 1.49% lower and 0.88% higher over the past week, respectively.

Merrimack Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs for the treatment of immunological and autoimmune diseases.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Merrimack Pharma.

Log in and add Merrimack Pharma (MACK) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights merrimack pharma

Ticker(s): MACK